Mucoadhesive buccal films containing carvedilol were prepared using the solvent casting method. Sodium alginate was used as bioadhesive polymer and different ratios of sodium alginate to PVP K-30 were used. Drug: HPβ-CD complex was incorporated in the buccoadhesive film to improve the dissolution of poorly water soluble drug from the polymeric film. The films were evaluated for their physical characteristics like mass variation, drug content uniformity, folding endurance, in vitro mucoadhesion strength, in vitro mucoadhesion time, surface pH, in vitro drug release, and in vitro buccal permeation study. Films exhibited controlled release for a period of 8 h. The release rate from optimized film best fitted Korsemeyer and Peppas (R 2 =0.9996), followed by zero order (R 2 =0.9963) and the value of n =1.1655 indicated that release from film followed Super Case II transport. The optimized film was subjected to stability study and histopathological examination on porcine buccal mucosa. Also the film was found to be stable in human saliva, no color change was observed. Histopathological studies revealed no effect on the mucosal histology after application of film for 10 hrs. The optimized formulation
Introduction
Buccal delivery of drug provides an attractive alternative to the oral route of drug administration. In recent years, delivery of therapeutic agents through various transmucosal routes gained significant attention owing to their presystemic metabolism or instability in the acidic environment associated with oral administration. Buccal delivery provides direct entry into the systemic circulation, thus avoiding the hepatic first-pass effect, ensuring ease of administration, and making it possible to terminate delivery when required. Carvedilol is a non-selective and β-adrenergic antagonist with no intrinsic sympatomimetic activity and is widely used to treat essential hypertension and angina pectoris. Although it is completely absorbed from the gastrointestinal tract, the systemic availability is approximately 25-35 % because of high first-pass metabolism. Since the buccal route bypasses the hepatic first pass effect, the dose of carvedilol could be reduced. The physicochemical properties of carvedilol, its suitable half life, low molecular weight 406.5, and its low dose (6.25-25 mg) makes it *Corresponding Author:
pateljaymin9@gmail.com suitable candidate for administration by buccal route. Thus in this study the attempt was taken for preparation of buccoadhesive films by using bioadhesive polymers like sodium alginate and PVP K-30 which will improve oral bioavailability by sparing the drug from first pass metabolism and reduce the dosing frequency. Drug: HPβ-CD complex was incorporated in the buccoadhesive film to improve the dissolution of poorly water soluble drug from the polymeric film.
Materials and Methods

Materials
Carvedilol, Hydroxypropyl-β-Cyclodextrin and Ethocel (20 cps) was obtained from Cipla Ltd., Kurkumbh (Dist.Pune), Roquette Fereres, France and Colorcon Asia Pvt. Ltd., Goa respectively. The other reagents used were of analytical grade.
Method Preparation of Drug: HPβ-CD complex
Inclusion complex of carvedilol with hydroxypropyl beta cyclodextrin (HP -CD) in the ratio 1:1 was prepared by kneading method.
Formulation and development of buccoadhesive film
Films containing different polymers were prepared by the solvent casting method. First the rate controlling layer of ethyl cellulose (3%) was cast and then drug: HP -CD containing polymeric layer was cast over it. The composition of all films is given in Table 1 Evaluation of buccoadhesive film Film thickness: The thickness of patches was measured at three different places using Tablet Tester (Campbell Electronics, Mumbai, Model CWWTDDH 500N). (Table 2 ) Film weight: Films of specified area (3.14 cm 2 ) were cut and were weighed individually using Electronic weighing balance (Model No.AW-220 and BX -6205, Shimadzu Corporation, Japan). (Table 2 ) Drug content: Film of specified area (3.14 cm 2 ) was dissolved in methanol, and the drug content was found out. (Table 2 ) Folding endurance: Folding endurance of the film was determined by repeatedly folding one film at the same place till it broke. (Table 2 ) Surface pH measurement: Buccal films were left to swell for 2 h on the surface of an agar plate, prepared by dissolving 2% (m/V) agar in warmed isotonic phosphate buffer of pH 6.8. The surface pH was measured by means of a pH paper placed on the surface of the swollen film. The surface pH of all buccal films was between 6-7. (Table 2) Swelling study: Buccal film was weighed (W1), placed in a 2% agar gel plate and incubated at 37 ± 1°C. At regular one-hour time intervals (to 2 h), the film was removed from the Petri dish and excess surface water was removed carefully using the filter paper. The swollen films were then reweighed (W2) and the swelling index (SI) were calculated. SI = (W2-W1) / W1 X 100 (Table 2) In vitro bioadhesion time:
The in vitro mucoadhesion time was performed after application of the films on freshly cut porcine buccal mucosa. The porcine buccal tissues were fixed on the internal side of a beaker with cyano acrylate glue. Each film was divided in portions of 4 cm 2 and cut; a side of each film was wetted with small quantity of simulated saliva fluid and was pasted to the porcine buccal tissue by applying a light force with the finger tip for 20 s. The beaker was filled with 200 ml of the simulated saliva fluid and was kept at 37 °C. After 2 min, it was stirred at 50 rpm;
to simulate the buccal cavity environment and film adhesion was monitored over 8 hr.
In vitro bioadhesive strength
Bioadhesive strength of the film was measured on a modified physical balance using the method described by Gupta et al.
The following parameters were calculated from the bioadhesive strength.
Force of adhesion (N) = bioadhesive strength 9.81 X 1000
Bond strength (N m-2) = Surface area force of adhesion
In vitro drug release
The drug release was determined using USP dissolution test apparatus Type II thermostated at 37±1°C and stirred at rate of 50 rpm. Each film was fixed on a glass slide with the help of cyano acrylate adhesive so that the drug could be released only from upper face. Slide was immersed in vessel containing simulated salivary solution (pH 6.8).
Aliquots were withdrawn at regular intervals and replaced with equal volume of dissolution medium.
In vitro permeation studies
For in vitro permeation studies, porcine buccal mucosa was used. The permeation study was carried out by using Keshary-Chein diffusion cell. The method used porcine buccal mucosa as the model mucosal membrane. The membrane was placed between the donor compartment (salivary pH 6.8) and the reservoir compartment (isotonic phosphate buffer pH 7.4, blood pH) to mimic the physiological conditions. The diffusion cell was thermostated at 37±1°C. Aliquots were withdrawn at regular intervals and replaced with equal volume of dissolution medium.
Results and Discussion
The drug content in the prepared complex was found to be 97.08%, and the results of XRD revealed that the drug was present in amorphous state in the complex (Fig 1,2,3,4) . The prepared films were smooth in appearance, uniform in thickness, mass and drug content. The films exhibited good folding endurance. Film thickness ranged from 0.52 mm -1.17 mm and film weight ranged from 37.76 mg-42.56 mg. The surface pH of the prepared buccoadhesive films ranged from 6-7, that indicates no risk of mucosal irritation or damage. The swelling index of the prepared films was found to be in the order of F7 > F4 > F5 > F6 > F3 > F2 > F1. Water uptake might also be more due to presence of HPβ-CD in the film. The bioadhesive strength of the prepared buccoadhesive film was in the following order: F1 > F2 > F3 > F4 > F5 > F6 > F7. Sodium alginate has a greater portion of hydroxyl group (OH) than the other polymers, and therefore gets hydrated easily and forms a strong gel that entangles tightly with the mucin molecules. The bioadhesive strength was affected by the proportion of sodium alginate present in the film. PVP K-30 enhanced drug release and swelling index but significantly decreased the bioadhesive strength. The in vitro bioadhesion time of the prepared films was found to be dependent on the percentage of sodium alginate in the film. (Table 3 )
In vitro drug release
In vitro drug release studies indicated that drug release was dependent on the percentage of polymers used and the swelling of the individual polymer in the combination used. The drug release from sodium alginate film was controlled by the formation of a hydrated viscous layer formed when the film comes in contact with the dissolution medium, which in turn depends on the concentration of polymer used (Table13). This viscous layer act as a barrier to drug release by opposing the penetration of dissolution medium into the matrices and the movement of the dissolved solutes out of the matrices. Cappello B., et al. 49 and Jug M., et al, 50 showed that HPβ-CD act as channeling or wicking agent promoting the dissolution of the poorly water soluble drug inside the polymeric matrix. Although the marked increase in surface area during swelling and presence of HPβ-CD can promote drug release, the increase in diffusional path length of drug may paradoxically delay the release. The drug release increased with addition of PVP K-30 which also depends on the percentage of PVP K-30 in the film. (Table 4) In vitro permeation The order of drug permeation from buccoadhesive film was in the following order; F3 > F2 > F1 > F7 > F6 > F5 > F4. (Table 5 ). Based on swelling, bioadhesion and drug release and drug permeation profile F3 was selected as optimized film which showed appropriate swelling, duration of bioadhesion, drug release and permeation and hence considered for further stability studies.
Kinetic Treatment to dissolution data of F3
The dissolution data of F3 was treated with different kinetic equations to interpret the order of release of carvedilol and the coefficients of determination (R 2 ).
Results indicated that the release rate from film F3 best fitted Korsemeyer and Peppas (R 2 =0.9996), followed by zero order (R 2 =0.9963) and then square root t kinetics (R 2 =0.9075). The value of n =1.1655 indicated that release from film followed Super Case II transport. This mechanism could result from increased plasticization at the relaxing boundary (gel layer).
Stability in human saliva
The stability of carvedilol buccoadhesive film was examined in natural human saliva. Films were placed in separate Petri dishes containing 5 mL of human saliva and kept in a temperature controlled incubator for 8hr at 37 ± 0.2 °C. At regular time intervals (0, 1, 2, 3 and 8hr), the film were examined for changes in color, shape and collapse of the film. (Table 6 ).
Cyclodextrin have been suggested to act as penetration enhancer. They enhance the permeation of the drug by carrying the drug through the aqueous barrier towards the surface of the membrane, where the drug passes from complex into the membrane. Based on swelling, bioadhesion and drug release and drug permeation profile F3 was selected as optimized film which showed appropriate swelling, duration of bioadhesion, drug release and permeation and hence considered for further stability studies.
Histopathological examination on porcine buccal mucosa
Histological analyses were performed to evaluate the pathological changes occurring in cell morphology and tissue organization. Histological studies revealed that the porcine buccal epithelium maintained the integrity even after application of buccoadhesive film for 10hrs.
Stability study of film (F3)
The film F3 was selected as an optimized film and the stability study was carried out at accelerated condition of 40 ± 2 0 C/ 75 ± 5% RH conditions for period of three months. After each month film was analyzed for physical characteristics, bioadhesion properties, duration of bioadhesion and the in vitro drug release study. The methods adopted were same as described earlier. (Table 7 3months at 40 ± 2°C, 75 ± 5% RH, as there was no significant change in dissolution profile of film over a period of study (p>0.05) and as the value of similarity factor f2 for dissolution profile after l month, 2month and 3month were 99.86, 99.83 and 99.85 respectively. Similarly, no significant difference was observed in bioadhesion study (p>0.05)
Conclusion
From the present investigation, it can be concluded that optimized buccoadhesive film of carvedilol with the combination of 70% sodium alginate and 30% PVP K-30 can meet the ideal requirements for buccal devices, which can be a good way to bypass the extensive hepatic first pass metabolism. 
